RESEARCH PAPER
The breast-conserving surgery of women with breast cancer in Podlaskie Voivodeship (Poland). Population study
 
More details
Hide details
1
Department of Public Health, Medical University of Bialystok, Poland
2
Department for Health Problems of Ageing, Institute of Rural Health in Lublin, Poland
3
National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
4
Higher School of Public Health, Zielona Góra, Poland
 
Ann Agric Environ Med. 2013;20(2):395–400
 
KEYWORDS
ABSTRACT
Introduction. The results of breast cancer treatment depend mainly on better detection in mammography screening and, consequently, a higher proportion of women with early stage of the disease. They depend also on a better access to health care services and the effectiveness of oncological treatment. One of the methods of breast cancer control is a breast-conserving surgery. With a proper patients’ classification for the treatment, the results of the breast-conserving surgery do not differ in relation to mastectomy. That’s why, the availability of breast-conserving surgical methods is particularly important, especially in a population in which a population screening is conducted. Objective. The analysis of the selected aspects of the breast cancer treatment’s standard in Podlaskie Voivodeship. Patients and methods. In years 2001–2002, 709 cases of women with breast cancer were reported to the Voivodeship Cancer Registry in Bialystok. 659 women were diagnosed with a primary invasive breast cancer. Based on a cohort of 499 women treated with radical methods the following indicators, recommended by WHO for the evaluation of the breast-conserving surgery’s availability, were calculated: a percentage of patients with whom breast-conserving surgery was used, a proportion of breast cancer cases receiving post-operative breast radiotherapy after breast-conserving surgery and a proportion of breast-conserving surgery in pT1 cases. Results. The breast-conserving surgery has been used much less frequently in Podlaskie Voivodeship than in Western Europe, but more frequently than in Poland in general. Conclusion. It should be aimed to provide a surgical treatment with the use of breast-conserving surgical methods to the highest possible percentage of patients. The increase of the percentage of patients treated with breast-conserving surgery methods can be a result of an effective screening realisation.
 
REFERENCES (27)
1.
Berrino F, Capocaccia R. Survival of European cancer patients. In: Coleman MP. (Ed) Responding to the challenge of cancer in Europe. Institute of Public Health of the Republic of Slovenia 2008: 151–175.
 
2.
Bojar I, Biliński P, Boyle P, Zatoński W, Marcinkowski J, Wojtyła A. Prevention of female reproductive system cancer among rural and urban Polish pregnant women. Ann Agric Environ Med. 2011; 18: 183–188.
 
3.
Kornafel J, Bidziński M, Gawrychowski K, Rzepka-Górska I, Urbański K, Zieliński J. Ginekologia onkologiczna. In: Krzakowski M, editor. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych. Część I. Onkologia w Praktyce Klinicznej; 2007, 3, suppl. C. p. 283–321.
 
4.
Jassem J: Rak piersi. In: Krzakowski M, (Ed.). Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych. Część I. Onkologia w Praktyce Klinicznej; 2007, 3, suppl. C. p. 179–222.
 
5.
Kietlińska Z, Zieliński J, Rustowski J, Wittczak-Ploch E, Sablińska B. Zasady postępowania onkologicznego w praktyce ogólnolekarskiej. Centrum Onkologii-Instytut im. M. Skłodowskiej-Curie, Warszawa; 1991.
 
6.
Early Breast Cancer Trialists’ Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. NEJM 1995; 333: 1444–55.
 
7.
Fisher B, Anderson S, Redmond C, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. NEJM 1995; 333: 1456- 61.
 
8.
Early Breast Cancer Trialists` Collaborative Group (EBCTCG). Radiotherapy for early breast cancer. Cochrane Database Syst Rev. 2002; 2: CD003647.
 
9.
Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Trial. N Engl J Med. 1997; 337: 949–55.
 
10.
Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen. DBCG 82c. Lancet 1999; 353: 1641–8.
 
11.
Farber S, Diamond LK, Mercer RD, et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroylglutamic acid (aminopterin). N Engl J Med. 1948; 238: 787–793.
 
12.
Gage I, Recht A, Gelman R, et al. Long-term outcome following breastconserving surgery and radiation therapy. Int J Radiat Oncology Biol Phys. 1995; 33: 245–51.
 
13.
Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J Clin. 1998; 48: 83–107.
 
14.
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of randomized study comparing breast saving burgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227–1232.
 
15.
EUROCHIP European Cancer Health Indicator Project-II. The Action. Final Scientific Report European Commission Directorate for Public Health and Safety at Work 31/03/2008. http://www.tumori. net/eurochip/.
 
16.
EUROCHIP II European Cancer Health Indicator Project Final Report European Commission Directorate for Public Health and Safety at Work 15/07/2003. http://www.tumori.net/eurochip... 17. EUROCHIP III European Cancer Health Indicator Project-III Interim Scientific Report European Commission Directorate for Public Health and Safety at Work 30/04/2010. http://www.tumori.net/eurochip....
 
17.
Esteban D, Whelan S, Laudico A, Parkin DM. Manual for Cancer Registry Personnel. Lyon: International Agency for Research on Cancer; 1995.
 
18.
Allemani C, Storm H, Voogd AC, Holli K, Izarzugaza I, Torrella-Ramos A, Bielska-Lasota M, et al. Variation in ‘standard care’ for breast cancer across Europe: A EUROCARE-3 high resolution study, European Journal of Cancer 2010; 46: 1528–1536.
 
19.
Nowicki A, Krajewski E, Maruszak M. Wczesne wyniki leczenia raka gruczołu piersiowego metodą oszczędzającą. Współczesna Onkologia 2006; 10: 85–91.
 
20.
Krzyzak M, Maslach D, Bielska-Lasota M, Juczewska M, Rabczenko D, Marcinkowski JT, Szpak A. Breast cancer survival gap between urban and rural female population in Podlaskie Voivodship, Poland, in years 2001–2002. Population study. Ann Agric Environ Med. 2010;17: 277–282.
 
21.
Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H, Forman D. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer. 2008; 44: 992–9.
 
22.
Siesling S, van de Poll-Franse LV, Jobsen JJ, Repelaer van Driel OJ, Voogd AC. Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990–2001. Breast 2007; 16: 606–14.
 
23.
Barlow WE, Stephen H. Taplin SH, Cathleen K. Yoshida CK, Buist DS, Seger D, Brown M. Cost Comparison of Mastectomy Versus BreastConserving Therapy for Early-Stage Breast Cancer. Journal of the National Cancer Institute 2001; 93: 447–455.
 
24.
Campbell JD, Ramsey SD. The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics 2009; 27(3): 199–209.
 
25.
Munoz E, Shamash F, Friedman M, Teicher I, Wise L. Lumpectomy vs mastectomy. The costs of breast preservation for cancer. Arch Surg. 1986; 121: 1297–301.
 
26.
Desch CE, Penberthy LT, Hillner BE, McDonald MK, Smith TJ, Pozez AL, et al. A sociodemographic and economic comparison of breast reconstruction, mastectomy, and conservative surgery. Surgery 1999; 125: 441–7.
 
27.
Norum J, Olsen JA, Wist EA. Lumpectomy or mastectomy? Is breast conserving surgery too expensive? Breast Cancer Res Treat. 1997; 45: 7–14.
 
eISSN:1898-2263
ISSN:1232-1966